CodeMap® Compliance Briefing: October 20, 2016
The federal government, through the Office of Inspector General (OIG) and Department of Justice (DOJ), continues to scrutinize clinical laboratories and many of their business practices. In particular, these agencies have focused their energy on laboratories that promote or allow the ordering of testing that is not medically necessary, but rather financially benefits the laboratory. Without exception, press releases accompanying enforcement actions and/or settlements stress the importance that both physicians and laboratories treat Medicare beneficiaries without financial considerations influencing their decisions or clouding their judgements. During the next two weeks, our CodeMap® Compliance Briefings will explore two differe....
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.